Stock-Split Watch: Could These 2 Market-Beaters Be Next?
For moves that don't improve the underlying strength of a company's business, stock splits garner a lot of attention, at least when conducted by prominent corporations. In part, that's because they make it easier for investors on a budget to purchase a single share. So when a stock starts getting too expensive, it could be a sign that the company may conduct a stock split relatively soon.
Let's consider two stocks that have beaten the market in recent years and, some would say, are overdue for a split: (NASDAQ: MELI) and Regeneron Pharmaceuticals (NASDAQ: REGN).
MercadoLibre is the leading e-commerce platform in Latin America. However, the company's services extend far beyond e-commerce. MercadoLibre created an ecosystem that gives merchants access to all the tools they need to be successful online retailers, from payment processing and shipping solutions to the ability to create and customize an online storefront. Like many other e-commerce leaders, MercadoLibre saw its shares soar in the early days of the pandemic, only to drop substantially between 2021 and 2022 once that tailwind ended.
Source Fool.com
Mercadolibre Inc Stock
The stock is an absolute favorite of our community with 29 Buy predictions and no Sell predictions.
On the other hand, the target price of 1853 € is below the current price of 1865.8 € for Mercadolibre Inc, so the potential is actually -0.69%.
